Childhood Origins of Asthma (COAST) (COAST)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00204841 |
Recruitment Status :
Completed
First Posted : September 20, 2005
Last Update Posted : July 15, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Asthma Allergy |
Study Type : | Observational |
Actual Enrollment : | 287 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Rhinovirus Infection and Asthma in Childhood and Adolescents |
Actual Study Start Date : | October 1998 |
Actual Primary Completion Date : | June 30, 2019 |
Actual Study Completion Date : | June 30, 2019 |
- Evaluate the children longitudinally for the inception and progression of asthma. [ Time Frame: Birth through age 19 ]Clinical diagnosis of childhood asthma at age 6 years and older.
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 2 Minutes (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- children who had one or more parent with a history of allergy or asthma
Exclusion Criteria:
- pre term infants
- low birth weight infants
- respiratory distress at birth

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00204841
United States, Wisconsin | |
University of Wisconsin | |
Madison, Wisconsin, United States, 53792 |
Principal Investigator: | Daniel J Jackson, MD | University of Wisconsin, Madison | |
Principal Investigator: | Robert F Lemanske, Jr., MD | University of Wisconsin, Madison |
Responsible Party: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00204841 |
Other Study ID Numbers: |
1998-129 P01HL070831 ( U.S. NIH Grant/Contract ) 2013-0144 ( Other Identifier: UW IRB ) H-2007-0044 ( Other Identifier: UW IRB ) |
First Posted: | September 20, 2005 Key Record Dates |
Last Update Posted: | July 15, 2019 |
Last Verified: | July 2019 |
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |